ROSENBERGER BRIAN (VP, Commercial) sold 11.8% of their position (12.66K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/25/2023ACC: 0001062993-23-001385
Officer· VP, Commercial
Since Jan 2019
+107.34K
Net shares
Net buyer
$7.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
120K acquired · 12.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−12.66K
Price / share
$0.60
Trade value
$7.57K
% of position
11.8%
1/23/2023
107.51K→94.85K
Common Stock
Direct
Shares
+120K
Price / share
—
Trade value
—
% of position
126.5%
1/24/2023
94.85K→214.85K
Total
Net shares
+107.34K
Net value
-$7.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2023 | S · Sale | −12.66K | $0.60 | $7.57K | 11.8% | 107.51K | 94.85K |
| Common Stock Direct | 1/24/2023 | A · Award | +120K | — | — | 126.5% | 94.85K | 214.85K |
| Total | +107.34K | -$7.57K | ||||||
Derivative Transactions0
No derivative transactions reported